U.S., March 28 -- ClinicalTrials.gov registry received information related to the study (NCT07498231) titled 'COronoary Microcirculation Analysis NETwork' on March 23.
Brief Summary: COMA.NET (COronary Microcirculation Analysis NETwork) is a prospective, randomized, open-label, parallel-group clinical trial designed to determine whether endotype-guided pharmacotherapy is superior to standard care in improving quality of life in patients with - Ischemia with Non-Obstructive Coronary Arteries. Approximately 180-190 participants with objective ischemia, will be randomized to either control or the intervention group.
Pharmacotherapy based on endotype established during intracoronary assessment, will be introduced in the intervention arm of th...